Jaikumkao, Krit; Pongchaidecha, Anchalee; Chueakula, Nuttawud; Thongnak, La-ongdao; Wanchai, Keerati; Chatsudthipong, Varanuj; Chattipakorn, Nipon; Lungkaphin, Anusorn (2018). Dapagliflozin, a SGLT2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, ER stress, and apoptosis in pre-diabetic rats. Diabetes, Obesity and Metabolism, (), –.
doi:10.1111/dom.13441
url to share this paper:
An interview with Sci-Hub Founder Alexandra Elbakyan Who exactly should pay for academic research